Dr. Gregory Zanieski, MD

Dr. Zanieski practices at Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut.

Dr. Zanieski's NPI, 1235320474, was assigned on August 5, 2007. Dr. Zanieski graduated from State University of New York at Stony Brook, School of Medicine in 2002. Dr. Zanieski holds Connecticut license 62463.

Dr. Zanieski's primary practice is Yale New Haven Psychiatric Hospital (York St), at 20 York Street, New Haven, CT 06510. The practice phone is (203) 688-5900.

Dr. Zanieski's primary practice is Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut. Dr. Zanieski is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Zanieski to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zanieski practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Zanieski's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Zanieski's licenses on file in 3 states: Connecticut, New York and Pennsylvania.

CMS data shows 96 Medicare services from Dr. Zanieski across 2 procedure codes in 2024, all of them office visits, for 108 Medicare patients. Medicare paid $6,292 for them. Every service was in an office.

CMS counts 108 Medicare patients who saw Dr. Zanieski in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have cancer, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zanieski's median patient age at 71, with 96% women.

In 2022, Dr. Zanieski wrote 13 Medicare Part D claims. They cover 1 drug, with $20 in total drug cost. In 2021, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Zanieski for performance year 2024, reported as part of a group. Dr. Zanieski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of mastectomy by Dr. Zanieski, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Zanieski, published from 2021 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Carcinoma, Ductal, Breast and Mastectomy. Dr. Zanieski has published most often in Ann Surg Oncol. Dr. Zanieski's most frequent co-authors are Mehra Golshan, MD, Donald Rowe Lannin, MD and Anees B. Chagpar, MD.

Dmand AI links Dr. Zanieski to 4 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Anxiety Disorders. Alliance for Clinical Trials in Oncology sponsors the most, 2.

CMS Open Payments shows 1 general payment to Dr. Zanieski from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Endomagnetics Ltd paid the most, $27.

Dr. Zanieski graduated from State University of New York at Stony Brook, School of Medicine in 2002.